wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52668213-53831E1D-2193-4F29-95B2-5586C08B80A4
Q52668213-53831E1D-2193-4F29-95B2-5586C08B80A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52668213-53831E1D-2193-4F29-95B2-5586C08B80A4
Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia.
P2860
Q52668213-53831E1D-2193-4F29-95B2-5586C08B80A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52668213-53831E1D-2193-4F29-95B2-5586C08B80A4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d3c5c3d8943eb95363272f0bf5d0a1c7b17b242
P2860
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.